4,0
17 mag 2026
Ex dipendente, più di 10 anni
Boston, MA
Consiglia
Gradimento del CEO
Pronostico commerciale
Vantaggi
Good company benefits. Strong leadership in Oncology Account Group segment. Pipeline from 2029 and beyond looks strong. The Oncology Key Account Role offers a lot of diverse experiences and is an asset to the teams
Svantaggi
Does not pay at high level in comparison to other smaller companies in sales/ commercial side.